Vivacelle Bio
Manufacturing · Missouri, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2300 Main St Ste 900, Kansas City, Misso...Phone Number
(318) 771-1294Website
www.vivacellebio.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Vivacelle Bio
Vivacelle Bio, Inc. is a biopharmaceutical company focused on the discovery of life-saving interventions in critical illnesses due to a broad range of causes such as injuries resulting from warfare, major motor vehicle collisions or septic shock. Vivacelle Bio has a pipeline of products based upon its transformational phospholipid nanotechnology.Explore more
Vivacelle Bio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Vivacelle Bio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Vivacelle Bio recently announced quarterly report
Funding: Get notified immidiatlly once Vivacelle Bio has new funding data
Check out if Vivacelle Bio is spiking on competitors!
Check if Vivacelle Bio has recently received funding, and reach out quickly before it becomes old news!
Vivacelle Bio, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Click to see if Vivacelle Bio had a recent Job posting/layoffs
Product Launch: Get notified when Vivacelle Bio launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Vivacelle Bio
Recommended Actions
Find VP level buyers at Vivacelle Bio
Find 3 more new buyers
Compare Similar Companies to Vivacelle Bio
Compare insights from companies similar to Vivacelle Bio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Vivacelle Bio is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Vivacelle Bio is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Vivacelle Bio.
Vivacelle Bio financials insights
Gather financial insights about Vivacelle Bio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2014
Debt
$1.3M
Vivacelle Bio Tech Stack
A closer look at the technologies used by Vivacelle Bio
See more technologies
Vivacelle Bio News & Media
Vivacelle Bio Enrolls First Patient in Phase 3 Trial of Hypovolemia Due to Septic Shock for Phospholipid Nanoparticle-Based VBI-S
Septic shock results in approximately 350,000 deaths in the U.S. each year, the leading cause of hospital-related mortality and a major financial burden for the medical system Six trial sites with expertise in critical care across diverse geographies have been approved KANSAS CITY, Mo.,...Vivacelle Bio Initiates Phase 3 Trial for Lead Asset VBI-S to Treat Patients with Hypovolemia Due to Septic Shock
Vivacelle's VBI-S is designed to treat hypovolemic patients in urgent need of care due to septic shock Septic shock impacts approximately two million people in the U.S. each year, the leading cause of hospital-related mortality and a major financial burden for the medical system KANSAS...Vivacelle Bio's President and Chief Innovation Officer to Present Data Highlighting the Company's Late-Stage Clinical Programs at the BIO International Convention 2024
Vivacelle is advancing a robust pipeline of therapies for shock and trauma-induced conditions Vivacelle's pipeline is led by VBI-S, a Phase 3-ready asset designated for the treatment of hypotension and hypovolemia in septic shock patients, and VBI-1, a Phase 2-ready candidate for...Vivacelle Bio and University of Missouri-Kansas City School of Medicine Announce Groundbreaking Results from Phase 2a Clinical Trial of VBI-S for Refractory Hypotension in Severe Septic Shock Patients
KANSAS CITY, Mo., Feb. 29, 2024 /PRNewswire/ -- Today, researchers at Vivacelle Bio, Inc., a pioneering biotechnology company revealed the compelling outcomes of their phase 2a clinical trial of the investigational cardiovascular support fluid, VBI-S, in patients with severe septic shock....
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Vivacelle Bio
Sign Up For FreeTo access detailed company insights
Vivacelle Bio, Inc. is a biopharmaceutical company focused on the discovery of life-saving interventions in critical illnesses due to a broad range of causes such as injuries resulting from warfare, major motor vehicle collisions or septic shock. Vivacelle Bio has a pipeline of products based upon its transformational phospholipid nanotechnology.... Read More
